Heron Therapeutics, Inc. (HRTX)
NASDAQ: HRTX · Real-Time Price · USD
1.780
+0.040 (2.30%)
At close: Nov 1, 2024, 4:00 PM
1.740
-0.040 (-2.25%)
After-hours: Nov 1, 2024, 6:59 PM EDT
Heron Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 1, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 270 | 255 | 297 | 931 | 1,923 | 2,116 | |
| Market Cap Growth | 279.70% | -14.16% | -68.06% | -51.60% | -9.13% | 4.57% | |
| Enterprise Value | 381 | 358 | 333 | 892 | 1,690 | 1,878 | |
| Last Close Price | 1.78 | 1.70 | 2.50 | 9.13 | 21.16 | 23.50 | |
| PE Ratio | - | -2.12 | -1.50 | -4.07 | -8.45 | -9.39 | |
| PS Ratio | 2.01 | 2.01 | 2.76 | 10.78 | 21.69 | 14.50 | |
| PB Ratio | -13.90 | -7.51 | 21.90 | 12.00 | 8.13 | 5.24 | |
| P/FCF Ratio | -23.41 | -4.23 | -2.00 | -4.51 | -10.03 | -16.06 | |
| P/OCF Ratio | -25.30 | -4.34 | -2.02 | -4.58 | -10.40 | -16.99 | |
| EV/Sales Ratio | 2.80 | 2.82 | 3.10 | 10.33 | 19.06 | 12.86 | |
| EV/EBITDA Ratio | -24.40 | -3.97 | -2.00 | -4.18 | -7.69 | -9.00 | |
| EV/EBIT Ratio | -22.05 | -3.85 | -1.97 | -4.12 | -7.59 | -8.91 | |
| EV/FCF Ratio | -28.19 | -5.93 | -2.24 | -4.32 | -8.82 | -14.25 | |
| Debt / Equity Ratio | -4.71 | -5.29 | 11.60 | 2.06 | 0.10 | 0.05 | |
| Debt / FCF Ratio | -7.93 | -2.98 | -1.06 | -0.77 | -0.13 | -0.15 | |
| Asset Turnover | 0.65 | 0.54 | 0.39 | 0.26 | 0.20 | 0.30 | |
| Inventory Turnover | 2.19 | 2.42 | 3.07 | 3.89 | 6.27 | 7.16 | |
| Quick Ratio | 1.76 | 1.76 | 1.66 | 2.72 | 2.44 | 4.46 | |
| Current Ratio | 2.38 | 2.37 | 2.49 | 3.58 | 3.07 | 4.95 | |
| Return on Equity (ROE) | - | - | -399.43% | -140.53% | -70.99% | -52.91% | |
| Return on Assets (ROA) | -8.58% | -24.56% | -38.01% | -41.04% | -32.11% | -27.01% | |
| Return on Capital (ROIC) | -13.97% | -36.71% | -51.84% | -54.31% | -40.63% | -32.99% | |
| Earnings Yield | -17.83% | -43.34% | -61.24% | -23.71% | -11.82% | -9.68% | |
| FCF Yield | -8.34% | -23.65% | -50.04% | -22.17% | -9.97% | -6.22% | |
| Buyback Yield / Dilution | -31.37% | -26.87% | -10.57% | -8.48% | -11.00% | -11.73% | |
| Total Shareholder Return | -31.37% | -26.87% | -10.57% | -8.48% | -11.00% | -11.73% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.